CareCloud, MCIS ready ambulatory platform offering

CareCloud and MCIS, a healthcare IT company established from within the Marshfield Clinic in Marshfield, Wisc., announced a partnership to deliver a joint, cloud-based solution to help improve the clinical, financial and administrative outcomes of large ambulatory medical practices. 

The two parties have joined together MCIS’ clinical solutions-–including a physician-designed EHR, patient portal and population health management tool--with CareCloud’s practice management and medical billing software and services. The integrated solution includes unified customer implementation and support and is geared to large practices across dozens of specialties.

CareCloud Concierge is a revenue cycle management solution that combines CareCloud’s practice management software with the services of its billing and collections teams. CareCloud Concierge also features a collection of advanced billing rules via its CollectiveIQ offering and a comprehensive Advanced Analytics suite.

“At the heart of this partnership is interoperability,” said Albert Santalo, founder and CEO of CareCloud, in an interview with Clinical Innovation + Technology. “The fact that our two systems can be equally integrated speaks to the capabilities and philosophies we both employ. Most large IT companies do not integrate well at all. They think of it as a competitive advantage to be closed.”

The organizations have been in contact for about two years and working on this offering for several months. The solution builds off MCIS’ experience with supporting a multi-specialty group of more than 700 physicians, according to Peter Shave, MCIS chief architect.

Partnering with CareCloud will allow MCIS clients to optimize their financial results and experience improved clinical workflow, Shave said.

“It’s important to have seamless integration between the financial and clinical parts,” said Santalo. On the clinical side, he noted, "there can be a lot of variation between providers that can be based on a lot of different things so there’s not always one system that can enable that integration.”

“We know that there’s interest in what we’re doing out there,” said Shave. By combining the two organizations’ offerings, “we really believe we have a premium offering that will be of interest to the market.”

With more than 60 employees dedicated to the ongoing development of the EMR product, “we have a long roadmap of adding much more advanced features in the future,” said Shave.

The joint offering will become commercially available next week at the HIMSS Annual Conference & Exhibition in Chicago.

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.